Huang Y - Search Results

1

Angiopep-2-functionalized nanoparticles enhance transport of protein drugs across intestinal epithelia by self-regulation of targeted receptors.

Liu X, Wu R, Li Y, Wang L, Zhou R, Li L, Xiang Y, Wu J, Xing L, Huang Y. Liu X, et al. Among authors: huang y. Biomater Sci. 2021 Apr 21;9(8):2903-2916. doi: 10.1039/d1bm00020a. Epub 2021 Feb 18. Biomater Sci. 2021. PMID: 33599658

2

The targeting of 14-succinate triptolide-lysozyme conjugate to proximal renal tubular epithelial cells.

Zhang Z, Zheng Q, Han J, Gao G, Liu J, Gong T, Gu Z, Huang Y, Sun X, He Q. Zhang Z, et al. Among authors: huang y. Biomaterials. 2009 Mar;30(7):1372-81. doi: 10.1016/j.biomaterials.2008.11.035. Epub 2008 Dec 18. Biomaterials. 2009. PMID: 19100618

3

Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.

Jin Y, Song Y, Zhu X, Zhou D, Chen C, Zhang Z, Huang Y. Jin Y, et al. Among authors: huang y. Biomaterials. 2012 Feb;33(5):1573-82. doi: 10.1016/j.biomaterials.2011.10.075. Epub 2011 Nov 16. Biomaterials. 2012. PMID: 22093292

4

Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates.

Yang Y, Zhou Z, He S, Fan T, Jin Y, Zhu X, Chen C, Zhang ZR, Huang Y. Yang Y, et al. Among authors: huang y. Biomaterials. 2012 Mar;33(7):2260-71. doi: 10.1016/j.biomaterials.2011.12.007. Epub 2011 Dec 19. Biomaterials. 2012. PMID: 22189143

5

Preparation, macrophages targeting delivery and anti-inflammatory study of pentapeptide grafted nanostructured lipid carriers.

Zhao C, Fan T, Yang Y, Wu M, Li L, Zhou Z, Jian Y, Zhang Q, Huang Y. Zhao C, et al. Among authors: huang y. Int J Pharm. 2013 Jun 25;450(1-2):11-20. doi: 10.1016/j.ijpharm.2013.04.030. Epub 2013 Apr 20. Int J Pharm. 2013. PMID: 23612355

6

Penetratin derivative-based nanocomplexes for enhanced intestinal insulin delivery.

Zhu X, Shan W, Zhang P, Jin Y, Guan S, Fan T, Yang Y, Zhou Z, Huang Y. Zhu X, et al. Among authors: huang y. Mol Pharm. 2014 Jan 6;11(1):317-28. doi: 10.1021/mp400493b. Epub 2013 Nov 25. Mol Pharm. 2014. PMID: 24255985

7

Doxorubicin-loaded, charge reversible, folate modified HPMA copolymer conjugates for active cancer cell targeting.

Li L, Yang Q, Zhou Z, Zhong J, Huang Y. Li L, et al. Among authors: huang y. Biomaterials. 2014 Jun;35(19):5171-87. doi: 10.1016/j.biomaterials.2014.03.027. Epub 2014 Apr 1. Biomaterials. 2014. PMID: 24702960

8

Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles.

Zhou Z, Li L, Yang Y, Xu X, Huang Y. Zhou Z, et al. Among authors: huang y. Biomaterials. 2014 Aug;35(24):6622-35. doi: 10.1016/j.biomaterials.2014.04.059. Epub 2014 May 10. Biomaterials. 2014. PMID: 24814427

9

Comparison of active and passive targeting of doxorubicin for somatostatin receptor 2 positive tumor models by octreotide-modified HPMA copolymer-doxorubicin conjugates.

He S, Zhou Z, Li L, Yang Q, Yang Y, Guan S, Zhang J, Zhu X, Jin Y, Huang Y. He S, et al. Among authors: huang y. Drug Deliv. 2016;23(1):285-96. doi: 10.3109/10717544.2014.911991. Epub 2014 May 28. Drug Deliv. 2016. PMID: 24865288 Free article.

10

Targeting prostate carcinoma by G3-C12 peptide conjugated N-(2-hydroxypropyl)methacrylamide copolymers.

Yang Y, Li L, Zhou Z, Yang Q, Liu C, Huang Y. Yang Y, et al. Among authors: huang y. Mol Pharm. 2014 Oct 6;11(10):3251-60. doi: 10.1021/mp500083u. Epub 2014 Jun 30. Mol Pharm. 2014. PMID: 24955652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82,158 results

Search Page

Filters